Meyka Pro banner
ZimVie Inc.

ZimVie Inc. Fundamental Analysis (NASDAQ: ZIMV)

ZIMV●NASDAQ
HealthcareMedical - Devices
$18.99
$0.00(0.00%)
U.S. Market opens in 1h 28m

ZimVie Inc. Fundamental Analysis (NASDAQ: ZIMV)

ZimVie Inc. (NASDAQ: ZIMV) shows weak financial fundamentals with a PE ratio of -20.20, profit margin of -5.74%, and ROE of -6.53%. The company generates $0.5B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position14.41%
PEG Ratio-0.14
Current Ratio1.92

Areas of Concern

ROE-6.53%
Operating Margin-4.59%
We analyze ZIMV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 16.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
16.4/100

We analyze ZIMV's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZIMV struggles to generate sufficient returns from assets.

ROA > 10%
-3.43%

Valuation Score

Excellent

ZIMV trades at attractive valuation levels.

PE < 25
-20.20
PEG Ratio < 2
-0.14

Growth Score

Weak

ZIMV faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ZIMV maintains a strong and stable balance sheet.

Debt/Equity < 1
0.61
Current Ratio > 1
1.92

Profitability Score

Weak

ZIMV struggles to sustain strong margins.

ROE > 15%
-652.81%
Net Margin ≥ 15%
-5.74%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ZIMV Expensive or Cheap?

P/E Ratio

ZIMV trades at -20.20 times earnings. This suggests potential undervaluation.

-20.20

PEG Ratio

When adjusting for growth, ZIMV's PEG of -0.14 indicates potential undervaluation.

-0.14

Price to Book

The market values ZimVie Inc. at 1.36 times its book value. This may indicate undervaluation.

1.36

EV/EBITDA

Enterprise value stands at 12.77 times EBITDA. This signals the market has high growth expectations.

12.77

How Well Does ZIMV Make Money?

Net Profit Margin

For every $100 in sales, ZimVie Inc. keeps $-5.74 as profit after all expenses.

-5.74%

Operating Margin

Core operations generate -4.59 in profit for every $100 in revenue, before interest and taxes.

-4.59%

ROE

Management delivers $-6.53 in profit for every $100 of shareholder equity.

-6.53%

ROA

ZimVie Inc. generates $-3.43 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.43%

Following the Money - Real Cash Generation

Operating Cash Flow

ZimVie Inc. generates limited operating cash flow of $14.59M, signaling weaker underlying cash strength.

$14.59M

Free Cash Flow

ZimVie Inc. generates weak or negative free cash flow of $7.71M, restricting financial flexibility.

$7.71M

FCF Per Share

Each share generates $0.27 in free cash annually.

$0.27

FCF Yield

ZIMV converts 1.40% of its market value into free cash.

1.40%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-20.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.14

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.36

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.19

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.61

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.92

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.07

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How ZIMV Stacks Against Its Sector Peers

MetricZIMV ValueSector AveragePerformance
P/E Ratio-20.2030.72 Better (Cheaper)
ROE-6.53%561.00% Weak
Net Margin-5.74%7023.00% Weak
Debt/Equity0.610.51 Neutral
Current Ratio1.925.76 Neutral
ROA-3.43%-161.00% (disorted) Weak

ZIMV outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ZimVie Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ